Back to CRVS
ProShare Advisors LLC CRVS Position History
Corvus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$126K
Q3 2026
Peak value
$191K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $94K |
| Q4 2025 | $106K |
| Q1 2026 | $191K |
| Q2 2026 | $174K |
| Q3 2026 | $126K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $126K | 10.9K | — | — |
| Q2 2026 | $174K | 11.6K | — | — |
| Q1 2026 | $191K | 13.0K | — | — |
| Q4 2025 | $106K | 13.8K | — | — |
| Q3 2025 | $94K | 12.8K | — | — |